Source: EV Battery Tech.
  • EV Battery Tech (ACDC) has closed its oversubscribed non-brokered private placement for total gross proceeds of $900,000
  • The company issued a total of 4,500,000 units at a price of $0.20 per unit
  • Net proceeds will be used for the development of its crypto mining facility, marketing and general working capital
  • Extreme Vehicle Battery Technologies provides scalable, smart solutions for the electric vehicle and energy storage markets
  • EV Battery Tech (ACDC) opened trading at C$0.10 per share

EV Battery Tech (ACDC) has closed its previously announced oversubscribed non-brokered private placement for total gross proceeds of $900,000.

“This private placement shows the considerable strength of the company and the faith investors have in its long-term business plan,” stated Bryson Goodwin, President and CEO of EV Battery Tech.

The company issued a total of 4,500,000 units at a price of $0.20 per unit. Each unit consists of one common share and one share purchase warrant. Each warrant is exercisable into one additional common share at a price of $0.25 for a period of three years.

Warrants are subject to an acceleration clause.

All securities issued are subject to a four-month hold period.

Net proceeds will be used for the development of its crypto mining facility, marketing and general working capital.

Extreme Vehicle Battery Technologies provides scalable, smart solutions for the electric vehicle and energy storage markets.

EV Battery Tech (ACDC) opened trading at C$0.10 per share.

More From The Market Online

Biotech company patenting world’s first AI voice test for substance abuse

Biotech company MindBio files a patent application for the world's first AI model to detect substance abuse though vocal analysis.

Big tech earnings week: AI’s moment of truth for record valuations

AI faces its ROI test, investors want profits, not just promises. Spending under scrutiny as massive AI capex must drive growth and margins.

Paramount and Blue Ant Media ink exclusive Canadian ad deal

Paramount names Blue Ant Media as its exclusive direct sales and programmatic partner for ads on Paramount+ and Pluto TV in Canada.

2 biotech stocks bridging the gap between unmet need and next-gen medicine

Exploring Lunai Bioworks and TheraCryf, two biotech stocks taking early strides towards improving the lives of tens of millions of patients.